CA46604F1099
© Newsfile
31.12.2025
IZO
LISTED
CSE
Izotropic Announces AGM Results
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - December 31, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
IZO
LISTED
CSE
Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation
News Preview
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - November 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© Newsfile
28.10.2025
IZO
LISTED
CSE
Izotropic Launches "Breast Imaging News" Page on BreastCT.com
News Preview
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
24.10.2025
IZO
LISTED
CSE
Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System
News Preview
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
23.10.2025
IZO
LISTED
CSE
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Artificial intelligence (AI) continues to transform healthcare innovation, with medical imaging emerging as one of its most promising frontiers. In...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
IZO
LISTED
CSE
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 23, 2025 /CNW/ -- Artificial intelligence (AI) continues to transform healthcare innovation, with medical imaging emerging as one of its most promising frontiers. In breast...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
IZO
LISTED
CSE
Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Artificial intelligence (AI) continues to transform healthcare innovation, with medical imaging emerging as one of its most promising frontiers. In...
Themefolio
Profiler
Peergroup
© Newsfile
23.10.2025
IZO
LISTED
CSE
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook
News Preview
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
IZO
LISTED
CSE
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
News Preview
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and...
Themefolio
Profiler
Peergroup
© Newsfile
21.10.2025
IZO
LISTED
CSE
CEO.CA's Inside the Boardroom: This Breast Cancer Tech by Izotropic Targets 50% of Women Currently Underserved
News Preview
Toronto, Ontario--(Newsfile Corp. - October 21, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
IZO
LISTED
CSE
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer d...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
IZO
LISTED
CSE
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer d...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
21.10.2025
IZO
LISTED
CSE
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Oct. 21, 2025 /CNW/ -- Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer detectio...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
IZO
LISTED
CSE
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
IZO
LISTED
CSE
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatmen...
Themefolio
Profiler
Peergroup
© Newsfile
19.09.2025
IZO
LISTED
CSE
Izotropic Closes Non-Brokered Private Placement and Engages Awareness Consultants
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
IZO
LISTED
CSE
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Newsfile
10.09.2025
IZO
LISTED
CSE
Izotropic Gains Visibility as AI Market Broadens Beyond Tech
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 10, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
IZO
LISTED
CSE
Izotropic Announces Non-Brokered Private Placement & Extends Warrants
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 26, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of br...
Themefolio
Profiler
Peergroup
© Newsfile
12.08.2025
IZO
LISTED
CSE
Izotropic Introduces New Corporate Website & Brand Identity
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of br...
Themefolio
Profiler
Peergroup
© Newsfile
15.07.2025
IZO
LISTED
CSE
Izotropic Prepares New Platforms to Educate and Engage
News Preview
- Strategic awareness initiatives underway ahead of IzoView commercialization -- Company podcast and breasct.com website in development to expand engagement -- Market-facing activities aligned with investor communications and corporate milestones -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - July 15, 2025) - Izotropic C...
Themefolio
Profiler
Peergroup
© Newsfile
13.06.2025
IZO
LISTED
CSE
Izotropic Provides Marketing Update
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Newsfile
10.06.2025
IZO
LISTED
CSE
Izotropic Revises License Agreement with The Regents of the University of California
News Preview
- License agreement enables U.S. FDA approval or foreign equivalent (CE mark) -- Amendment aligns with Company's timelines for IzoView product launch -- Agreement amendment fees of USD $85K payable in installments -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 10, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZO...
Themefolio
Profiler
Peergroup
© EQS Newswire
20.05.2025
IZO
LISTED
CSE
FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
News Preview
- Die Übereinstimmung mit den Vorgaben der FDA wurde bestätigt. Der Weg zu der wichtigen klinischen Studie in den USA ist somit frei -- 150-seitiger strategischer Geschäftsplan und genaue Finanzmodelle fertiggestellt -- Kontaktaufnahme mit Investoren zur Finanzierung der klinischen Durchführung und des Markteintritts im Gange -Vancouver, British Co......
Themefolio
Profiler
Peergroup
© Newsfile
20.05.2025
IZO
LISTED
CSE
FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
News Preview
- Die Übereinstimmung mit den Vorgaben der FDA wurde bestätigt. Der Weg zu der wichtigen klinischen Studie in den USA ist somit frei -- 150-seitiger strategischer Geschäftsplan und genaue Finanzmodelle fertiggestellt -- Kontaktaufnahme mit Investoren zur Finanzierung der klinischen Durchführung und des Markteintritts im Gange -V...
Themefolio
Profiler
Peergroup
© Newsfile
17.05.2025
IZO
LISTED
CSE
Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
News Preview
- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to fund clinical execution and market entry -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - May 16, 2025) - Izotropic Corporation...
Themefolio
Profiler
Peergroup
© Newsfile
02.04.2025
IZO
LISTED
CSE
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Newsfile
02.04.2025
IZO
LISTED
CSE
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Newsfile
25.03.2025
IZO
LISTED
CSE
Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication
News Preview
- FDA meeting facilitated positive collaborative exchange -- Key topics included the clinical study protocol synopsis, the benefits versus risks of contrast-enhancement, and the management of breast cancers found on IzoView Breast CT that are not visible on digital breast tomosynthesis -- Izotropic to submit meeting minutes to the FDA prior to more...
Themefolio
Profiler
Peergroup
© Newsfile
10.03.2025
IZO
LISTED
CSE
Izotropic to Present at Investor Conference March 13th
News Preview
- CEO to discuss IzoView's competitive advantage, expansion strategy, and potential revenue models -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors, advisors, and analysts welcome -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - March 10, 2025) - Izotropic Corporation (C...
Themefolio
Profiler
Peergroup
© Newsfile
19.02.2025
IZO
LISTED
CSE
FDA Sets Meeting Date with Izotropic
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treat...
Themefolio
Profiler
Peergroup
© Newsfile
14.02.2025
IZO
LISTED
CSE
Izotropic Closes Non-Brokered Private Placement
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 14, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treat...
Themefolio
Profiler
Peergroup
© Newsfile
07.02.2025
IZO
LISTED
CSE
Izotropic Announces Non-Brokered Private Placement
News Preview
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 7, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based prod...
Themefolio
Profiler
Peergroup
© Newsfile
06.02.2025
IZO
LISTED
CSE
Izotropic Reschedules Investor Conference Presentation to March 13th
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 5, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatm...
Themefolio
Profiler
Peergroup
© Newsfile
03.02.2025
IZO
LISTED
CSE
Izotropic to Present at Investor Conference February 6th
News Preview
- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors, advisors, and analysts welcome -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 3, 2025) - Izotropic Corporation...
Themefolio
Profiler
Peergroup
© Newsfile
29.01.2025
IZO
LISTED
CSE
Izotropic Announces Timelines and Milestones to IzoView Product Launch
News Preview
- Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA submission by ~6 months -- 3 Site U.S.-based clinical study enables early data collection to kickstart European CE Mark Application -- Company to announce development of 2 new medical imaging devices in the next 12 months to tr...
Themefolio
Profiler
Peergroup
© Newsfile
17.01.2025
IZO
LISTED
CSE
Izotropic Featured in Announcement of Research and Markets' U.S. Breast Cancer Analysis and Forecast
News Preview
- Company listed in Research and Markets' announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - "U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the foreca...
Themefolio
Profiler
Peergroup
© Newsfile
15.01.2025
IZO
LISTED
CSE
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
News Preview
-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food and Drug Administration--New Biostatistical Consultant is the former Deputy Director of the Biostatistics and Data Management Center of the American College of Radiology Imaging Network, an NIH-funded cooperative that conduct...
Themefolio
Profiler
Peergroup
© Newsfile
09.01.2025
IZO
LISTED
CSE
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
News Preview
-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView scans by over 800%1 for initial approval and product launch- -Regulatory strategy responds to the "urgent call2" from the U.S. Preventative Services Task Force for solutions to finding breast cancers earlier in w...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2024
IZO
LISTED
CSE
Izotropic Provides Update on Annual General Meeting Materials and Voting Procedures
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, announces that due to the suspension of mail service in Canada due to the nationwide strike of the...
Themefolio
Profiler
Peergroup
© Newsfile
23.08.2024
IZO
LISTED
CSE
Izotropic Announces Regulatory Approval Plans to Launch Izoview for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 23, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a breast CT (computed tomography) imaging system, is pleased to announce that it is pursuing a regulatory strategy in the U...
Themefolio
Profiler
Peergroup
© Newsfile
14.06.2024
IZO
LISTED
CSE
Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") - Further to the Company's news release of June 6, 2024, the Company is pleased to announce that it has completed the first tranche of its non-brokered private placement financing (the "Offe...
Themefolio
Profiler
Peergroup
© Newsfile
06.06.2024
IZO
LISTED
CSE
Izotropic Corporation Announces Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, announced today that it intends to complete a small non-brokered private placement financing (the...
Themefolio
Profiler
Peergroup
© EQS Newswire
31.01.2024
IZO
LISTED
CSE
Izotropic erhält Antwort von der US-Behörde FDA
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 31. Januar 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView vermarktet (ein anatomisches CT-Bildgebungssystem für nicht-invasive Gewebecharakterisierung mit einer Anwendung in der Brustbildgebun......
Themefolio
Profiler
Peergroup
© Newsfile
31.01.2024
IZO
LISTED
CSE
Izotropic erhält Antwort von der US-Behörde FDA
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 31. Januar 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView vermarktet (ein anatomisches CT-Bildgebungssystem für nicht-invasive Gewebecharakterisierung mit einer Anwend...
Themefolio
Profiler
Peergroup
© Newsfile
30.01.2024
IZO
LISTED
CSE
Izotropic Receives Response From U.S. FDA
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive characterization of tissue with an application in...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.01.2024
IZO
LISTED
CSE
Izotropic gibt Updates zu regulatorischen und betrieblichen Themen
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 10. Januar 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView vermarktet (ein anatomisches CT-Bildgebungssystem für nicht-invasive Gewebecharakterisierung mit einer Anwendung in der Brustbildgebun......
Themefolio
Profiler
Peergroup
© Newsfile
10.01.2024
IZO
LISTED
CSE
Izotropic gibt Updates zu regulatorischen und betrieblichen Themen
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 10. Januar 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView vermarktet (ein anatomisches CT-Bildgebungssystem für nicht-invasive Gewebecharakterisierung mit einer Anwend...
Themefolio
Profiler
Peergroup
© Newsfile
08.01.2024
IZO
LISTED
CSE
Izotropic Provides Regulatory and Operational Updates
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive characterization of tissue with an application in b...
Themefolio
Profiler
Peergroup
© Newsfile
01.11.2023
IZO
LISTED
CSE
Izotropic Completes Pre-Submission Meeting with U.S. FDA
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 1, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive tissue characterization with an applicat...
Themefolio
Profiler
Peergroup
© Newsfile
29.09.2023
IZO
LISTED
CSE
Izotropic bestätigt Besprechungstermin mit der FDA vor der Antragseinreichung
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 29. September 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView vermarktet (ein anatomisches CT-Bildgebungssystem für nicht-invasive Gewebecharakterisierung mit sein...
Themefolio
Profiler
Peergroup
© Newsfile
27.09.2023
IZO
LISTED
CSE
Izotropic Confirms FDA Pre-Submission Meeting Date
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive tissue characterization with...
Themefolio
Profiler
Peergroup
© Newsfile
20.09.2023
IZO
LISTED
CSE
Izotropic Closes Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive tissue characterization with the first appl...
Themefolio
Profiler
Peergroup
© Newsfile
12.09.2023
IZO
LISTED
CSE
Izotropic reicht Klasse II-Antrag auf Vorabgenehmigung bei der FDA ein und gibt Einzelheiten zu Prädikatsprodukten bekannt
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Montag, 11. September 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das IzoView auf den Markt bringt, ein CT (Computertomographie)-Bildgebungssystem, das Bilder der Anatomie zur nicht-inva...
Themefolio
Profiler
Peergroup
© Newsfile
06.09.2023
IZO
LISTED
CSE
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive tissue characterization with the first applicatio...
Themefolio
Profiler
Peergroup
© Newsfile
20.06.2023
IZO
LISTED
CSE
Izotropic Modifies Market Approval Pathway & Strategy
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a 360-degree computed tomography (CT) imaging system designed for breast imaging and cancer diagnosis, announced that it is modifying its U.S. FD...
Themefolio
Profiler
Peergroup
© Newsfile
08.06.2023
IZO
LISTED
CSE
Izotropic CEO Resigns
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical imaging device company, announces that effective May 31, 2023, Dr. John McGraw has resigned as Chief Executive Officer (CEO) for personal reasons and has stepped down from the Company's...
Themefolio
Profiler
Peergroup
© Newsfile
27.02.2023
IZO
LISTED
CSE
Mitglieder des technischen und wissenschaftlichen Teams von Izotropic setzen sich für die Kommerzialisierung der Brust-CT-Technologie ein
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Montag, 27. Februar 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das die dedizierte Brust-CT-Bildgebungsplattform (Computertomographie) IzoView für eine präzisere Erkennung und Diagnose von Brustkrebs v...
Themefolio
Profiler
Peergroup
© Newsfile
23.02.2023
IZO
LISTED
CSE
Izotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, releases state...
Themefolio
Profiler
Peergroup
© Newsfile
10.01.2023
IZO
LISTED
CSE
Izotropic veröffentlicht erstes Video von Izoview
News Preview
Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 10. Januar 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Medizintechnikunternehmen, das die spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für eine genauere Brustkrebserkennung und -...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
